TYG Index as a Novel Predictor of Clinical Outcomes in Advanced Chronic Heart Failure with Renal Dysfunction Patients

References

• Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–3287. doi:10.1093/cvr/cvac013
   PubMed Web of Science ®Google Scholar
• Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol. 2016;12(10):610–623. doi:10.1038/nrneph.2016.113
   PubMed Web of Science ®Google Scholar
• Ellison DH, Felker GM, Ingelfinger JR. Diuretic treatment in heart failure. New Engl J Med. 2017;377(20):1964–1975. doi:10.1056/NEJMra1703100
   PubMed Web of Science ®Google Scholar
• Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–380. doi:10.1038/nrneph.2017.51
   PubMed Web of Science ®Google Scholar
• Wang XL, Zhang W, Li Z, et al. Vascular damage effect of circulating microparticles in patients with ACS is aggravated by type 2 diabetes. Mol Med Rep. 2021;23(6). doi:10.3892/mmr.2021.12113
   Web of Science ®Google Scholar
• Otto S, Lütjohann D, Kerksiek A, et al. Increased cholesterol absorption is associated with In-stent-restenosis after stent implantation for stable coronary artery disease. Steroids. 2022;187:109079. doi:10.1016/j.steroids.2022.109079
   PubMed Web of Science ®Google Scholar
• Shigematsu K, Watanabe Y, Nakano H. Influences of hyperlipidemia history on stroke outcome; a retrospective cohort study based on the Kyoto Stroke Registry. BMC Neurol. 2015;15(1):44. doi:10.1186/s12883-015-0297-1
   PubMedGoogle Scholar
• Schlondorff D. Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis. 1993;22(1):72–82. doi:10.1016/s0272-6386(12)70171-3
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. doi:10.1093/eurheartj/ehz486
   PubMed Web of Science ®Google Scholar
• Ho PTB, Clark IM, Le LTT. MicroRNA-based diagnosis and therapy. Int J Mol Sci. 2022;23(13). doi:10.3390/ijms23137167
   Web of Science ®Google Scholar
• Köser CU, Ellington MJ, Cartwright EJ, et al. Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathogens. 2012;8(8):e1002824. doi:10.1371/journal.ppat.1002824
   PubMed Web of Science ®Google Scholar
• Ng CD, Elliott MR, Riosmena F, Cunningham SA. Beyond recent BMI: BMI exposure metrics and their relationship to health. SSM Popul Health. 2020;11:100547. doi:10.1016/j.ssmph.2020.100547
   PubMed Web of Science ®Google Scholar
• Xiao S, Wang Z, Zuo R, et al. Association of Systemic Immune Inflammation Index with All-Cause, cardiovascular disease, and cancer-related mortality in patients with cardiovascular disease: a cross-sectional study. J Inflamm Res. 2023;16:941–961. doi:10.2147/jir.S402227
   PubMed Web of Science ®Google Scholar
• Erdoğan A, Özkan E. Examining the relationship between the atherogenic index of plasma and coronary plaque burden: insights from a retrospective intravascular ultrasound analysis. J Med Palliat Care. 2024;5(1):23–28. doi:10.47582/jompac.1421199
   Google Scholar
• Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metabol Syndr. 2022;16(8):102581. doi:10.1016/j.dsx.2022.102581
   PubMedGoogle Scholar
• Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654–672. doi:10.1038/s41580-018-0044-8
   PubMed Web of Science ®Google Scholar
• Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721–737. doi:10.1038/nrneph.2016.145
   PubMed Web of Science ®Google Scholar
• Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766
   PubMed Web of Science ®Google Scholar
• Singh S, Sharma R, Kumari M, Tiwari S. Insulin receptors in the kidneys in health and disease. World J Nephrol. 2019;8(1):11–22. doi:10.5527/wjn.v8.i1.11
   PubMedGoogle Scholar
• Qin Z, Xu S, Yuan R, et al. Combination of TyG Index and GRACE risk score as long-term prognostic marker in patients with ACS complicated with T2DM undergoing PCI. Diabetes Metabol Syndr Obes. 2022;15:3015–3025. doi:10.2147/dmso.S376178
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
   PubMed Web of Science ®Google Scholar
• Wang S, Shi J, Peng Y, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20(1):82. doi:10.1186/s12933-021-01274-x
   PubMed Web of Science ®Google Scholar
• Yin T, Chen S, Zhu Y, et al. Insulin resistance, combined with health-related lifestyles, psychological traits and adverse cardiometabolic profiles, is associated with cardiovascular diseases: findings from the BHMC study. Food Funct. 2024;15(7):3864–3875. doi:10.1039/d4fo00941j
   PubMed Web of Science ®Google Scholar
• Jiang LY, Tian J, Yang YN, Jia SH, Shu Q. Acupuncture for obesity and related diseases: insight for regulating neural circuit. J Integr Med. 2024;22(2):93–101. doi:10.1016/j.joim.2024.03.001
   PubMedGoogle Scholar
• Yang Y, Huang X, Wang Y, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2. doi:10.1186/s12933-022-01732-0
   PubMed Web of Science ®Google Scholar
• Erdoğan A, Inan D, Genç Ö, et al. The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome. J Clin Med. 2023;12(19):6201. doi:10.3390/jcm12196201
   PubMed Web of Science ®Google Scholar
• Sun C, Hu L, Li X, et al. Triglyceride-glucose index’s link to cardiovascular outcomes post-percutaneous coronary intervention in China: a meta-analysis. ESC Heart Fail. 2024. doi:10.1002/ehf2.14679
   Web of Science ®Google Scholar
• Simha V. Management of hypertriglyceridemia. BMJ. 2020;371:m3109. doi:10.1136/bmj.m3109
   PubMedGoogle Scholar
• Amouzegar A, Honarvar M, Masoumi S, Tohidi M, Mehran L, Azizi F. Sex-specific trajectories of insulin resistance markers and reduced renal function during 18 years of follow-up: TLGS. J Clin Endocrinol Metab. 2023;108(6):e230–e239. doi:10.1210/clinem/dgac735
   PubMed Web of Science ®Google Scholar
• Gao YM, Chen WJ, Deng ZL, Shang Z, Wang Y. Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease. Front Endocrinol. 2023;14:1150980. doi:10.3389/fendo.2023.1150980
   PubMedGoogle Scholar
• Li M, Li L, Qin Y, et al. Elevated TyG index predicts incidence of contrast-induced nephropathy: a retrospective cohort study in NSTE-ACS patients implanted with DESs. Front Endocrinol. 2022;13:817176. doi:10.3389/fendo.2022.817176
   PubMed Web of Science ®Google Scholar
• Chahal RS, Chukwu CA, Kalra PR, Kalra PA. Heart failure and acute renal dysfunction in the cardiorenal syndrome. Clin Med. 2020;20(2):146–150. doi:10.7861/clinmed.2019-0422
   PubMed Web of Science ®Google Scholar
• Rim SJ, Leong-Poi H, Lindner JR, Wei K, Fisher NG, Kaul S. Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity. Circulation. 2001;104(22):2704–2709. doi:10.1161/hc4701.099580
   PubMed Web of Science ®Google Scholar
• Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361–377. doi:10.1038/s41581-018-0001-y
   PubMed Web of Science ®Google Scholar
• Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390. doi:10.1038/s41581-020-0278-5
   PubMed Web of Science ®Google Scholar